Medical and Pharmaceutical Scribe Therapeutics develops one-time cholesterol treatment without permanent gene editing Scribe instead wants one treatment to keep PCSK9 switched down for an extended period Joseph MortonAugust 20, 2026
AI and Autonomy White House cuts data centers, batteries from critical technology list The federal government has formally maintained a government-wide strategy for critical and emerging technologies since 2020 Joseph MortonAugust 19, 2026
Psychedelics Definium Therapeutics soars on Phase 3 trial win with LSD depression drug The rally follows year-to-date gains of nearly 175% Rowan DunneJune 24, 2026
AI and Autonomy Canada launches CAD$900 million defence strategy to advance quantum and AI capabilities Minister of National Defence David McGuinty announced the funding at the University of Waterloo Joseph MortonMarch 24, 2026
Medical and Pharmaceutical Allarity Therapeutics doses first patients in VA-funded small cell lung cancer trial The drug being examined, stenoparib, is also showing promise in ovarian cancer treatment Rowan DunneFebruary 24, 2026
Medical and Pharmaceutical Corvus rally continues as clinical optimism offsets dilution concerns Corvus strengthened its balance sheet by pricing an upsized public offering Joseph MortonJanuary 23, 2026
Medical and Pharmaceutical Researchers replicate natural immune signaling to improve cancer immunotherapy The work came from scientists at the University of Southampton’s Centre for Cancer Immunology Joseph MortonJanuary 13, 2026
Medical and Pharmaceutical Robotic-assisted bronchoscopy aids early diagnosis for lung cancer patients Lung cancer kills more people than colon, breast and prostate cancers combined Joseph MortonDecember 16, 2025
Medical and Pharmaceutical Galleri shows promise in large U.S. based clinical trial Researchers believe this approach could allow doctors to catch cancers much earlier Joseph MortonOctober 20, 2025
Medical and Pharmaceutical Evaxion shares spike as AI-designed melanoma vaccine data hits market The presentation will include information on the breadth, magnitude, and duration of T-cell responses following booster immunization Joseph MortonOctober 15, 2025